Abstract: This invention is designed to provide a device for sideways movement which will permit an element to move laterally, such as a set of portable x-ray equipment which is affixed to said device.

Abstract: A photovoltaic module may include a back glass including a cobalt oxide or copper oxide.

Abstract: A solar module includes a front support, a back support, an active layer, and a protector.

Abstract: The inventions described herein generally relate to photovoltaic or solar module design and fabrication and, more particularly, to modules utilizing thin film solar cells. In one aspect is described a solar module and method of making the same that has a shield material that is both an electrical insulator and a moisture barrier provided at a location corresponding to at least one hole that is used to route a wiring member, such that the shield material seals the at least one hole against moisture entering into the internal space and electrically insulates the wires of the wiring member from the at least one metallic layer of the back protective sheet.

Abstract: The present invention provides module structures and methods of manufacturing rigid or flexible photovoltaic modules employing thin film solar cells fabricated on flexible substrates, preferably on flexible metallic foil substrates. The solar cells may be Group IBIIIAVIA compound solar cells or amorphous silicon solar cells fabricated on thin stainless steel or aluminum alloy foils. In one embodiment, initially a solar cell string including two or more solar cells is formed by interconnecting the solar cells with conductive leads or ribbons. At least one bypass diode electrically connects conductive back surfaces of at least two solar cells. The bypass diode and the solar cells are encapsulated with support material and are packed with the protective shell such that the at least one bypass diode is placed between at least one solar cell and the bottom protective sheet.

Abstract: A process for preparing a crystalline form of candesartan cilexetil referred to as Form I, which has a content of Form II lower than 1% (w/w), is described. The process includes a seeding stage with a crystalline product, which mainly includes Form I, and a digestion stage. The invention also relates to the crystalline form, the pharmaceutical compositions containing it and its use for the preparation of a medicament for the treatment of hypertension. Candesartan cilexetil Form I has shown good stability under accelerated stability conditions, when the content of Form II is lower than 1% w/w.

Abstract: The present invention is directed to small interfering RNA molecules (siRNA) targeted against an allele of interest, and methods of using these siRNA molecules.

Abstract: The present invention is directed to small interfering RNA molecules (siRNA) targeted against an allele of interest, and methods of using these siRNA molecules.

Abstract: A downhole gas separator includes an external tube having a closed bottom and an open top; and an internal tube positioned eccentrically within the external tube and having an open bottom and a top adapted for connection to a production tube. The internal tube can alternatively be connected to a pump intake. The separator is positioned eccentrically within a casing, and provides for separation of gas from produced fluids before the fluids enter the production tube and/or pump.

Abstract: A downhole gas separator includes an external tube having a closed bottom and an open top; and an internal tube positioned eccentrically within the external tube and having an open bottom and a top adapted for connection to a production tube. The internal tube can alternatively be connected to a pump intake. The separator is positioned eccentrically within a casing, and provides for separation of gas from produced fluids before the fluids enter the production tube and/or pump.

Abstract: Comprises a dispersion of nanocorpuscles in an aqueous solution as a dispersant and a pharmaceutically acceptable alcohol as co-dispersant or cosolvent, said nanocorpuscles having at least one lipid bilayer comprising at least one biliar salt and at least one phospholipid with the general formula (I), in which R1 and R2 are the same as each other or different, being generally linear aliphatic residues with 12-22 carbon atoms, having up to 4 double cis bonds, preferably up to 3 double cis bonds; these nanocorpuscles having an average diameter lower than 500 nm; and including metallothioneine in their interior.

Abstract: 5-Pyridinyl-6-R.sub.2 -3-R.sub.1 -2(1H)-pyridinones (I), where R.sub.2 is hydrogen or lower alkyl and R.sub.1 is a cyano, a carbamoyl or an amino group are prepared: by reaction of 1-R.sub.2 -1-oxo-2-pyridinyl-3-dialkylaminopropane (II) with malonamide under solid-liquid or liquid-liquid phase transfer catalysis conditions to obtain 1,2-dihydro-2-oxo-6-R.sub.2 -5-pyridinylnicotinamide (IV), or by reaction of II with cyanoacetamide under solid-liquid or liquid-liquid phase transfer catalysis conditions to obtain 1,2-dihydro-2-oxo-6-R.sub.2 -5-pyridinylnicotinonitrile (III) and partially hydrolizing III to yield IV; finally the carbamoyl group of IV is converted to amino and 1,2-dihydro-2-oxo-6-R.sub.2 -5-pyridinyl-3-aminopyridin-2-one are obtained.

Abstract: A rotary payout device for recreational machines comprises a cover, a disk and a casing. The cover and casing are held together by six springs in contact with the undersides of the screw heads and the cover, making the joint between casing and the cover flexible.